ProQR Therapeutics NV banner

ProQR Therapeutics NV
F:0PQ

Watchlist Manager
ProQR Therapeutics NV Logo
ProQR Therapeutics NV
F:0PQ
Watchlist
Price: 1.689 EUR 5.23% Market Closed
Market Cap: €137.9m

Wall St Price Targets

0PQ Price Targets Summary
ProQR Therapeutics NV

Wall Street analysts forecast 0PQ stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 0PQ is 8.247 EUR with a low forecast of 3.63 EUR and a high forecast of 13.207 EUR.

Lowest Forecast
Price Target
3.63 EUR
115% Upside
Average Forecast
Price Target
8.247 EUR
388% Upside
Highest Forecast
Price Target
13.207 EUR
682% Upside
ProQR Therapeutics NV Competitors:
Price Targets
UFPT
UFP Technologies Inc
40% Upside
VRNS
Varonis Systems Inc
0% Upside
LH6
LHC Group Inc
43% Upside

Revenue
Forecast

51% / Year
Past Growth
65% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat
51% / Year
Past Growth
65% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat

Over the last 12 years, the compound annual growth rate for Revenue has been 51%. The projected CAGR for the next 3 years is 65%.

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 0PQ's stock price target?
Price Target
8.247 EUR

According to Wall Street analysts, the average 1-year price target for 0PQ is 8.247 EUR with a low forecast of 3.63 EUR and a high forecast of 13.207 EUR.

What is the Revenue forecast for ProQR Therapeutics NV?
Projected CAGR
65%

Over the last 12 years, the compound annual growth rate for Revenue has been 51%. The projected CAGR for the next 3 years is 65%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett